Status:
COMPLETED
The Status of Parathyroid Hormone Secretion in Covid-19 Patients
Lead Sponsor:
Bezmialem Vakif University
Collaborating Sponsors:
Didem Ertorul
Conditions:
COVID-19 Infection
Parathyroid Gland
Eligibility:
All Genders
18-100 years
Brief Summary
COVID-19 infection causes a hypersensitive immune reaction and widespread inflammation in various organs of the body, especially through cytokines in the lungs. This cytokine-mediated widespread infla...
Detailed Description
The coronavirus-2 (SARS-COV-2) virus, which can cause severe acute respiratory syndrome through the droplet, has caused the global Coronavirus 19 (COVID-19) pandemic. COVID-19 infection can be asympto...
Eligibility Criteria
Inclusion
- To accept research.
- Being over the age of 18.
- COVID 19 test results to be positive.
- Not taking parathyroid disease medication before.
- Receiving inpatient treatment in the COVID service in the hospital.
Exclusion
- Not accepting research.
- Be under the age of 18.
- Negative COVID 19 test results for patients.
- COVID patients treated as outpatient.
- Parathyroid disease in the healthy control group.
Key Trial Info
Start Date :
September 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 9 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04662437
Start Date
September 10 2020
End Date
December 9 2020
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem VU
Istanbul, Turkey (Türkiye), 34093